Clinical Trials Directory

Trials / Completed

CompletedNCT04189198

A Comparison of 4% Articaine Versus 0.5%Bupivacaine for Ambulatory Surgery Under Supraclavicular Block

A Randomized Controlled Trial : Comparison of 4% Articaine Versus 0.5% Bupivacaine for Ambulatory Orthopaedic Surgery Under Supraclavicular Block

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

Effect of 2%Articaine versus 5%bupivacaine in pt undergoing short duration surgery in upper limb

Detailed description

The investigator aim to compare Articaine 2% versus bupivacaine 0.5% in patient undergoing upper limb procedure under ultrasound guided supraclavicular block as regard onset and duration of sensory and motor block

Conditions

Interventions

TypeNameDescription
DRUGArticaineSupraclavicular block with 30 ml articaine 2%
DRUGBupivacaineSupraclavicular block with 30 ml bupivacaine 0.5%

Timeline

Start date
2019-12-30
Primary completion
2020-03-22
Completion
2020-03-27
First posted
2019-12-06
Last updated
2020-04-28

Locations

1 site across 1 country: Egypt

Regulatory

Source: ClinicalTrials.gov record NCT04189198. Inclusion in this directory is not an endorsement.

A Comparison of 4% Articaine Versus 0.5%Bupivacaine for Ambulatory Surgery Under Supraclavicular Block (NCT04189198) · Clinical Trials Directory